title: Cytogenetic and molecular characterization of a congenital mesoblastic nephroma.
abstract: A newborn baby boy was diagnosed with the mixed form of congenital mesoblastic nephroma (CMN) representing both classic and cellular histology features in the renal tumor. Additionally, the patient had skin and bone lesions consistent with multifocal involvement of a generalized infantile fibromatosis (IFS). Both skin and bone lesions were distinctly different from CMN and did not represent metastasis. The primary tumor cell line (MCH-MN-1), established from the resected right kidney tumor, had a diploid DNA content. Cytogenetic studies revealed deletion on the long arm of chromosome 3 (q21q24) and duplication on the short arm of chromosome 11 (p15). MCH-MN-1 cells expressed ETV6-NTRK3 gene fusion transcripts, characteristic of cellular and mixed forms of CMNs. The cells had high p21 and low Bax mRNA expression in the reverse transcriptase-polymerase chain reaction (RT-PCR) assay. The high level of proliferative marker (Ki67) mRNA expression correlated well with the pluripotent nature of MCH-MN-1 in tissue culture (cell doubling time = 12.4 h). Our results showed that MCH-MN-1 might be a good model cell line for investigations on mesoblastic nephroma.
authors.affiliation: Department of Pathology, Miami Children's Hospital, 3100 SW 62nd Avenue, Miami, FL 33155, USA.
authors.forename: C
authors.initials: C
authors.lastname: Ramachandran
authors.forename: S J
authors.initials: SJ
authors.lastname: Melnick
authors.forename: E
authors.initials: E
authors.lastname: Escalon
authors.forename: Z
authors.initials: Z
authors.lastname: Khatib
authors.forename: P
authors.initials: P
authors.lastname: Jhabvala
authors.forename: H B
authors.initials: HB
authors.lastname: Fonseca
authors.forename: S
authors.initials: S
authors.lastname: Smith
authors.forename: A
authors.initials: A
authors.lastname: Alamo
authors.forename: S
authors.initials: S
authors.lastname: Medina
mesh_terms: D002872:Chromosome Deletion; D017931:DNA Primers / Q000737:chemistry; D004273:DNA, Neoplasm / Q000032:analysis; D005350:Fibroma / Q000150:complications / Q000151:congenital / Q000235:genetics / Q000473:pathology; D005434:Flow Cytometry; D015972:Gene Expression Regulation, Neoplastic; D005819:Genetic Markers / Q000235:genetics; D006801:Humans; D007231:Infant, Newborn; D007621:Karyotyping; D007680:Kidney Neoplasms / Q000150:complications / Q000151:congenital* / Q000235:genetics / Q000473:pathology; D008297:Male; D018201:Nephroma, Mesoblastic / Q000150:complications / Q000151:congenital / Q000235:genetics / Q000473:pathology; D012333:RNA, Messenger / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014407:Tumor Cells, Cultured / Q000502:physiology
chemical_list: D017931:DNA Primers; D004273:DNA, Neoplasm; D005819:Genetic Markers; D012333:RNA, Messenger